• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Refinancing

Kartesia in €32m refinancing for Enterprise-backed Nu-Med

  • Katharine Hidalgo
  • Katharine Hidalgo
  • 27 November 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Kartesia has provided Enterprise Investors portfolio company Nu-Med with a €32m refinancing package.

The package will go towards refinancing all existing financial debt and supporting Nu-Med in its growth plan.

This is the first deal for Kartesia in Poland. Capital for the deal will be drawn from Kartesia Credit Opportunities (KCO) IV and V funds. The firm's fourth fund closed on €870m in October 2017 and offers debt and equity packages of €10-60m to European small and mid-cap companies. KCO V was registered in March 2019 and, according to Unquote Data, is still fundraising.

Nu-Med

  • DEAL:

    Refinancing

  • VALUE:

    €32m

  • LOCATION:

    Elblag

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    2013

Previous funding
Enterprise acquired a minority stake in the company in 2013, drawing equity from its Polish Enterprise Fund VII. The firm had invested €37.4m in the company as of January 2017.

Enterprise put the asset up for sale, with PwC advising, but did not achieve a sale, according to Unquote sister publication Mergermarket.

Company
Headquartered in Elblag, Poland, Nu-Med is a private operator of four oncology centres in Poland and was founded in 2013. 

People
Kartesia
– Giuseppe Mirante (head of DACH credit opportunities).
Nu-Med Group – Paweł Paczkowski (CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Refinancing
  • CEE
  • Healthcare
  • Poland
  • Refinancing
  • Kartesia

More on Refinancing

The Unquote Podcast
Unquote Private Equity Podcast: The PE auction in times of exit scarcity

Rachel Lewis joins Harriet Matthews to discuss how auction process dynamics are changing against the current market backdrop

  • Industry
  • 23 January 2023
Banks and financial institutions
Alcentra takes keys to three PE-backed companies this year

Under Benefit Street Partners' ownership the alternative lender took over Lifetime, Optionis and Equiom

  • Refinancing
  • 16 December 2022
Pharmaceuticals
Gyrus Capital's Essential Pharma refinances, inks two deals

In parallel with the refinancing, Essential Pharma completed two M&A deals in December

  • Refinancing
  • 22 December 2021
Catering for cruises and other marine vessels
Searchlight invests in Celestyal Cruises

Searchlight is investing in the cruise operator via its Searchlight Opportunities Fund

  • Refinancing
  • 29 November 2021

Latest News

Information technology consultants
  • Buyouts
Mobilab signs deal with Armira in crowded small-cap auction

Founder-owned data applications and infrastructure provider drew sponsor and strategic interest

  • 06 June 2023
Richard Kirkby of Veld Capital
  • People
AnaCap spin-out Veld makes team changes as it looks to raise its next fund

Hiring of Richard Kirkby and promotion of Konstantin Karchinov and Sebastien Wigdo comes eight months into the firm’s existence as an independent entity

  • 05 June 2023
New office opening in Milan
  • People
Golding opens office in Milan and appoints new head of Italy

Former managing director Laura Tardino will lead asset manager’s expansion in Southern Europe

  • 05 June 2023
Healthcare fundraising in euros
  • Funds
Archimed closes MED II on EUR 3.5bn

Healthcare-focused GP took 17 months to raise its second mid-cap fund, which has already deployed almost EUR 1bn

  • 05 June 2023
Back to Top

Most read

Information technology consultants
Mobilab signs deal with Armira in crowded small-cap auction
Richard Kirkby of Veld Capital
AnaCap spin-out Veld makes team changes as it looks to raise its next fund
New office opening in Milan
Golding opens office in Milan and appoints new head of Italy
Healthcare fundraising in euros
Archimed closes MED II on EUR 3.5bn
Eye surgery equipment
Eurazeo-backed DORC catches the eye of dealmakers with H2 process anticipated
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013